OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Implications of enigmatic transglutaminase 2 (TG2) in cardiac diseases and therapeutic developments
Doa’a Al-u’datt, Carole C. Tranchant, Ahmed Al‐Dwairi, et al.
Biochemical Pharmacology (2022) Vol. 201, pp. 115104-115104
Closed Access | Times Cited: 14
Doa’a Al-u’datt, Carole C. Tranchant, Ahmed Al‐Dwairi, et al.
Biochemical Pharmacology (2022) Vol. 201, pp. 115104-115104
Closed Access | Times Cited: 14
Showing 14 citing articles:
Tgm2‐Catalyzed Covalent Cross‐Linking of IκBα Drives NF ‐κB Nuclear Translocation to Promote SASP in Senescent Microglia
LI Zhi-qiang, Tianxiang Wang, Sijing Du, et al.
Aging Cell (2025)
Open Access
LI Zhi-qiang, Tianxiang Wang, Sijing Du, et al.
Aging Cell (2025)
Open Access
Heart‐derived factors and organ cross‐talk in settings of health and disease: new knowledge and clinical opportunities for multimorbidity
Melodi G. Sen, Roger Chooi, Julie R. McMullen
The Journal of Physiology (2025)
Closed Access
Melodi G. Sen, Roger Chooi, Julie R. McMullen
The Journal of Physiology (2025)
Closed Access
Atrial cardiomyocytes contribute to the inflammatory status associated with atrial fibrillation in right heart disease
Ewen Le Quilliec, Charles-Alexandre LeBlanc, Orlane Neuilly, et al.
EP Europace (2024) Vol. 26, Iss. 4
Open Access | Times Cited: 3
Ewen Le Quilliec, Charles-Alexandre LeBlanc, Orlane Neuilly, et al.
EP Europace (2024) Vol. 26, Iss. 4
Open Access | Times Cited: 3
Transglutaminases in fibrosis—overview and recent advances
Fatemeh Soltani, Mari T. Kaartinen
AJP Cell Physiology (2023) Vol. 325, Iss. 4, pp. C885-C894
Closed Access | Times Cited: 7
Fatemeh Soltani, Mari T. Kaartinen
AJP Cell Physiology (2023) Vol. 325, Iss. 4, pp. C885-C894
Closed Access | Times Cited: 7
Dynamic and static biomechanical traits of cardiac fibrosis
Han Liu, Pengbei Fan, Fanli Jin, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 12
Han Liu, Pengbei Fan, Fanli Jin, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 12
Transglutaminase 2 in diabetes mellitus: Unraveling its multifaceted role and therapeutic implications for vascular complications
Kwon‐Soo Ha
Theranostics (2024) Vol. 14, Iss. 6, pp. 2329-2344
Open Access | Times Cited: 2
Kwon‐Soo Ha
Theranostics (2024) Vol. 14, Iss. 6, pp. 2329-2344
Open Access | Times Cited: 2
Colchicine for the prevention of atrial fibrillation: Why do some studies say ‘yes’, and others say ‘no’?
Abir Attia, Roddy Hiram
International Journal of Cardiology (2024) Vol. 408, pp. 132110-132110
Closed Access | Times Cited: 2
Abir Attia, Roddy Hiram
International Journal of Cardiology (2024) Vol. 408, pp. 132110-132110
Closed Access | Times Cited: 2
Involvement and possible role of transglutaminases 1 and 2 in mediating fibrotic signalling, collagen cross-linking and cell proliferation in neonatal rat ventricular fibroblasts
Doa’a Al-u’datt, Carole C. Tranchant, Belal Al‐Husein, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0281320-e0281320
Open Access | Times Cited: 6
Doa’a Al-u’datt, Carole C. Tranchant, Belal Al‐Husein, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0281320-e0281320
Open Access | Times Cited: 6
Inhibition of transglutaminase 2 (TG2) ameliorates ventricular fibrosis in isoproterenol-induced heart failure in rats
Doa’a Al-u’datt, Carole C. Tranchant, Muhammad H. Alu’datt, et al.
Life Sciences (2023) Vol. 321, pp. 121564-121564
Closed Access | Times Cited: 5
Doa’a Al-u’datt, Carole C. Tranchant, Muhammad H. Alu’datt, et al.
Life Sciences (2023) Vol. 321, pp. 121564-121564
Closed Access | Times Cited: 5
Increased Osteoclastogenesis in Absence of TG2 Is Reversed by Transglutaminase Inhibition—Evidence for the Role for TG1 in Osteoclast Formation
Sahar Ebrahimi Samani, Mari T. Kaartinen
Cells (2023) Vol. 12, Iss. 17, pp. 2139-2139
Open Access | Times Cited: 4
Sahar Ebrahimi Samani, Mari T. Kaartinen
Cells (2023) Vol. 12, Iss. 17, pp. 2139-2139
Open Access | Times Cited: 4
Transglutaminase2: An Enduring Enzyme in Diabetes and Age-Related Metabolic Diseases
Neera Yadav, Sun Yeou Kim
Kinases and Phosphatases (2024) Vol. 2, Iss. 1, pp. 67-91
Open Access | Times Cited: 1
Neera Yadav, Sun Yeou Kim
Kinases and Phosphatases (2024) Vol. 2, Iss. 1, pp. 67-91
Open Access | Times Cited: 1
von Willebrand factor-binding protein (vWbp)-activated factor XIII and transglutaminase 2 (TG2) promote cross-linking between FnBPA from Staphylococcus aureus and fibrinogen
Chiara Motta, Angelica Pellegrini, Stefano Camaione, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Chiara Motta, Angelica Pellegrini, Stefano Camaione, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Transglutaminases in cardiovascular health and disease
Lakshmi Santhanam
Elsevier eBooks (2024), pp. 131-167
Closed Access
Lakshmi Santhanam
Elsevier eBooks (2024), pp. 131-167
Closed Access
von Willebrand factor-binding protein (vWbp)-activated Factor XIII and transglutaminase 2 (TG2) promote cross-linking between FnBPA from Staphylococcus aureus and fibrinogen
Chiara Motta, Angelica Pellegrini, Stefano Camaione, et al.
Research Square (Research Square) (2023)
Open Access
Chiara Motta, Angelica Pellegrini, Stefano Camaione, et al.
Research Square (Research Square) (2023)
Open Access
